Redica Systems has been assisting pharmaceutical companies in determining GMP quality risks at their manufacturing sites, and ...

Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between ...

The agency’s CHMP recommended drugs to treatments for hemophilia, two biosimilars for psoriasis, and two flu vaccines at their October meeting.

Regulators, EMA and HMA, have published principles and recommendations on the use of LLMs, which are being increasingly used ...

The agency has reconfirmed its recommendation to not give positive opinion to Translarna (ataluren) after a reexamination of the available data.

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective ...

Collecting and curating R&D data are increasingly crucial tasks for achieving the full benefits of advanced analytics. Many pharmaceutical and biotechnology organizations are rich in data but need ...

Amid surging drug shortages and costly launch delays, it’s crucial to enhance operational flexibility and efficiency without compromising quality. Discover how end-to- end integrated automation ...

Revolutionize pharmaceutical manufacturing through paperless manufacturing. By eliminating paper-based processes, you can quickly centralize your data, reduce cost and time, minimize errors, and ...

Andrew Lewis, PhD, Chief Scientific Officer, Quotient Sciences, discussed the CMC challenges with GLP-1 and oral peptides during CPHI Milan. During CPHI Milan, Andrew Lewis, PhD, chief scientific ...

Pharmaceutical Technology Europe chats with Klaus Ullherr, senior product manager at Syntegon, about challenges facing companies when trying to comply with Annex 1 and how automated systems can help.